Crossmark

Discordance of positive immunohistochemical results among different primary HER2 antibodies used in breast cancer: A comparison between Histofine® HER2 Kit (MONO) SV2-61γ antibody and Ventana I-VIEW PATHWAY™ HER2 4B5 antibody

Crossref DOI link: https://doi.org/10.1016/j.patol.2022.04.002

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Fujita, Kei

Yao, Takashi
License Information

Text and Data Mining valid from 2022-10-01
More Information

This article is maintained by: Elsevier

Article Title: Discordance of positive immunohistochemical results among different primary HER2 antibodies used in breast cancer: A comparison between Histofine® HER2 Kit (MONO) SV2-61γ antibody and Ventana I-VIEW PATHWAY™ HER2 4B5 antibody

Journal Title: Revista Española de Patología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.patol.2022.04.002

Content Type: article

Copyright: © 2022 Sociedad Española de Anatomía Patológica. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below